Mutagen Explained

In genetics, a mutagen is a physical or chemical agent that permanently changes genetic material, usually DNA, in an organism and thus increases the frequency of mutations above the natural background level. As many mutations can cause cancer in animals, such mutagens can therefore be carcinogens, although not all necessarily are. All mutagens have characteristic mutational signatures with some chemicals becoming mutagenic through cellular processes.

The process of DNA becoming modified is called mutagenesis. Not all mutations are caused by mutagens: so-called "spontaneous mutations" occur due to spontaneous hydrolysis, errors in DNA replication, repair and recombination.

Discovery

The first mutagens to be identified were carcinogens, substances that were shown to be linked to cancer. Tumors were described more than 2,000 years before the discovery of chromosomes and DNA; in 500 B.C., the Greek physician Hippocrates named tumors resembling a crab karkinos (from which the word "cancer" is derived via Latin), meaning crab.[1] In 1567, Swiss physician Paracelsus suggested that an unidentified substance in mined ore (identified as radon gas in modern times) caused a wasting disease in miners,[2] and in England, in 1761, John Hill made the first direct link of cancer to chemical substances by noting that excessive use of snuff may cause nasal cancer.[3] In 1775, Sir Percivall Pott wrote a paper on the high incidence of scrotal cancer in chimney sweeps, and suggested chimney soot as the cause of scrotal cancer.[4] In 1915, Yamagawa and Ichikawa showed that repeated application of coal tar to rabbit's ears produced malignant cancer.[5] Subsequently, in the 1930s the carcinogen component in coal tar was identified as a polyaromatic hydrocarbon (PAH), benzo[a]pyrene.[2] [6] Polyaromatic hydrocarbons are also present in soot, which was suggested to be a causative agent of cancer over 150 years earlier.

The association of exposure to radiation and cancer had been observed as early as 1902, six years after the discovery of X-ray by Wilhelm Röntgen and radioactivity by Henri Becquerel.[7] Georgii Nadson and German Filippov were the first who created fungi mutants under ionizing radiation in 1925.[8] [9] The mutagenic property of mutagens was first demonstrated in 1927, when Hermann Muller discovered that x-rays can cause genetic mutations in fruit flies, producing phenotypic mutants as well as observable changes to the chromosomes,[10] [11] visible due to the presence of enlarged "polytene" chromosomes in fruit fly salivary glands.[12] His collaborator Edgar Altenburg also demonstrated the mutational effect of UV radiation in 1928.[13] Muller went on to use x-rays to create Drosophila mutants that he used in his studies of genetics.[14] He also found that X-rays not only mutate genes in fruit flies,[10] but also have effects on the genetic makeup of humans.[15] Similar work by Lewis Stadler also showed the mutational effect of X-rays on barley in 1928,[16] and ultraviolet (UV) radiation on maize in 1936.[17] The effect of sunlight had previously been noted in the nineteenth century where rural outdoor workers and sailors were found to be more prone to skin cancer.[18]

Chemical mutagens were not demonstrated to cause mutation until the 1940s, when Charlotte Auerbach and J. M. Robson found that mustard gas can cause mutations in fruit flies.[19] A large number of chemical mutagens have since been identified, especially after the development of the Ames test in the 1970s by Bruce Ames that screens for mutagens and allows for preliminary identification of carcinogens.[20] [21] Early studies by Ames showed around 90% of known carcinogens can be identified in Ames test as mutagenic (later studies however gave lower figures),[22] [23] and ~80% of the mutagens identified through Ames test may also be carcinogens.[24] [25]

Difference between mutagens and carcinogens

Mutagens are not necessarily carcinogens, and vice versa. Sodium azide for example may be mutagenic (and highly toxic), but it has not been shown to be carcinogenic.[26] Meanwhile, compounds which are not directly mutagenic but stimulate cell growth which can reduce the effectiveness of DNA repair and indirectly increase the chance of mutations, and therefore that of cancer.[27] One example of this would be anabolic steroids, which stimulate growth of the prostate gland and increase the risk of prostate cancer among others.[28] Other carcinogens may cause cancer through a variety of mechanisms without producing mutations, such as tumour promotion, immunosuppression that reduces the ability to fight cancer cells or pathogens that can cause cancer, disruption of the endocrine system (e.g. in breast cancer), tissue-specific toxicity, and inflammation (e.g. in colorectal cancer).[29]

Difference between mutagens and DNA damaging agents

A DNA damaging agent is an agent that causes a change in the structure of DNA that is not itself replicated when the DNA is replicated.[30] Examples of DNA damage include a chemical addition or disruption of a nucleotide base in DNA (generating an abnormal nucleotide or nucleotide fragment), or a break in one or both strands in DNA. When duplex DNA containing a damaged base is replicated, an incorrect base may be inserted in the newly synthesized strand opposite the damaged base in the complementary template strand, and this can become a mutation in the next round of replication. Also a DNA double-strand break may be repaired by an inaccurate process leading to an altered base pair, a mutation. However, mutations and DNA damages differ in a fundamental way: mutations can, in principle, be replicated when DNA replicates, whereas DNA damages are not necessarily replicated. Thus DNA damaging agents often cause mutations as a secondary consequence, but not all DNA damages lead to mutation and not all mutations arise from a DNA damage.[30] The term genotoxic means toxic (damaging) to DNA.

Effects

See main article: Mutagenesis. Mutagens can cause changes to the DNA and are therefore genotoxic. They can affect the transcription and replication of the DNA, which in severe cases can lead to cell death. The mutagen produces mutations in the DNA, and deleterious mutation can result in aberrant, impaired or loss of function for a particular gene, and accumulation of mutations may lead to cancer. Mutagens may therefore be also carcinogens. However, some mutagens exert their mutagenic effect through their metabolites, and therefore whether such mutagens actually become carcinogenic may be dependent on the metabolic processes of an organism, and a compound shown to be mutagenic in one organism may not necessarily be carcinogenic in another.[31]

Different mutagens act on DNA differently. Powerful mutagens may result in chromosomal instability,[32] causing chromosomal breakages and rearrangement of the chromosomes such as translocation, deletion, and inversion. Such mutagens are called clastogens.

Mutagens may also modify the DNA sequence; the changes in nucleic acid sequences by mutations include substitution of nucleotide base-pairs and insertions and deletions of one or more nucleotides in DNA sequences. Although some of these mutations are lethal or cause serious disease, many have minor effects as they do not result in residue changes that have significant effect on the structure and function of the proteins. Many mutations are silent mutations, causing no visible effects at all, either because they occur in non-coding or non-functional sequences, or they do not change the amino-acid sequence due to the redundancy of codons.[33] Some mutagens can cause aneuploidy and change the number of chromosomes in the cell. They are known as aneuploidogens.[34]

In Ames test, where the varying concentrations of the chemical are used in the test, the dose response curve obtained is nearly always linear, suggesting that there may be no threshold for mutagenesis. Similar results are also obtained in studies with radiations, indicating that there may be no safe threshold for mutagens. However, the no-threshold model is disputed with some arguing for a dose rate dependent threshold for mutagenesis.[35] [10] Some have proposed that low level of some mutagens may stimulate the DNA repair processes and therefore may not necessarily be harmful. More recent approaches with sensitive analytical methods have shown that there may be non-linear or bilinear dose-responses for genotoxic effects, and that the activation of DNA repair pathways can prevent the occurrence of mutation arising from a low dose of mutagen.[36]

Types

Mutagens may be of physical, chemical or biological origin. They may act directly on the DNA, causing direct damage to the DNA, and most often result in replication error. Some however may act on the replication mechanism and chromosomal partition. Many mutagens are not mutagenic by themselves, but can form mutagenic metabolites through cellular processes, for example through the activity of the cytochrome P450 system and other oxygenases such as cyclooxygenase.[37] Such mutagens are called promutagens.[38]

Physical mutagens

Chemical mutagens

Chemical mutagens either directly or indirectly damage DNA. On this basis, they are of 2 types:

Directly acting chemical mutagens

They directly damage DNA, but may or may not undergo metabolism to produce promutagens (metabolites that can have higher mutagenic potential than their substrates).

Indirectly acting chemical mutagens

They are not necessarily mutagenic by themselves, but they produce promutagens mutagenic compounds through metabolic processes in cells.

Some chemical mutagens additionally require UV or visible light activation for their mutagenic effect. These are the, which include furocoumarins and limettin.[45]

Base analogs

Intercalating agents

Metals

Many metals, such as arsenic, cadmium, chromium, nickel and their compounds may be mutagenic, but they may act, however, via a number of different mechanisms.[46] Arsenic, chromium, iron, and nickel may be associated with the production of ROS, and some of these may also alter the fidelity of DNA replication. Nickel may also be linked to DNA hypermethylation and histone deacetylation, while some metals such as cobalt, arsenic, nickel and cadmium may also affect DNA repair processes such as DNA mismatch repair, and base and nucleotide excision repair.[47]

Biological agents

Protection

See main article: Antimutagen and Antioxidants. Antioxidants are an important group of anticarcinogenic compounds that may help remove ROS or potentially harmful chemicals. These may be found naturally in fruits and vegetables.[50] Examples of antioxidants are vitamin A and its carotenoid precursors, vitamin C, vitamin E, polyphenols, and various other compounds. β-Carotene is the red-orange colored compounds found in vegetables like carrots and tomatoes. Vitamin C may prevent some cancers by inhibiting the formation of mutagenic N-nitroso compounds (nitrosamine). Flavonoids, such as EGCG in green tea, have also been shown to be effective antioxidants and may have anti-cancer properties. Epidemiological studies indicate that a diet rich in fruits and vegetables is associated with lower incidence of some cancers and longer life expectancy, however, the effectiveness of antioxidant supplements in cancer prevention in general is still the subject of some debate.[51] [52]

Other chemicals may reduce mutagenesis or prevent cancer via other mechanisms, although for some the precise mechanism for their protective property may not be certain. Selenium, which is present as a micronutrient in vegetables, is a component of important antioxidant enzymes such as gluthathione peroxidase. Many phytonutrients may counter the effect of mutagens; for example, sulforaphane in vegetables such as broccoli has been shown to be protective against prostate cancer.[53] Others that may be effective against cancer include indole-3-carbinol from cruciferous vegetables and resveratrol from red wine.[54]

An effective precautionary measure an individual can undertake to protect themselves is by limiting exposure to mutagens such as UV radiations and tobacco smoke. In Australia, where people with pale skin are often exposed to strong sunlight, melanoma is the most common cancer diagnosed in people aged 15–44 years.[55] [56]

In 1981, human epidemiological analysis by Richard Doll and Richard Peto indicated that smoking caused 30% of cancers in the US.[57] Diet is also thought to cause a significant number of cancer, and it has been estimated that around 32% of cancer deaths may be avoidable by modification to the diet.[58] Mutagens identified in food include mycotoxins from food contaminated with fungal growths, such as aflatoxins which may be present in contaminated peanuts and corn; heterocyclic amines generated in meat when cooked at high temperature; PAHs in charred meat and smoked fish, as well as in oils, fats, bread, and cereal;[59] and nitrosamines generated from nitrites used as food preservatives in cured meat such as bacon (ascorbate, which is added to cured meat, however, reduces nitrosamine formation).[50] Overly-browned starchy food such as bread, biscuits and potatoes can generate acrylamide, a chemical shown to cause cancer in animal studies.[60] [61] Excessive alcohol consumption has also been linked to cancer; the possible mechanisms for its carcinogenicity include formation of the possible mutagen acetaldehyde, and the induction of the cytochrome P450 system which is known to produce mutagenic compounds from promutagens.[62]

For certain mutagens, such as dangerous chemicals and radioactive materials, as well as infectious agents known to cause cancer, government legislations and regulatory bodies are necessary for their control.[63]

Test systems

Many different systems for detecting mutagen have been developed.[64] [65] Animal systems may more accurately reflect the metabolism of human, however, they are expensive and time-consuming (may take around three years to complete), they are therefore not used as a first screen for mutagenicity or carcinogenicity.

Bacterial

See main article: Ames test.

Yeast

Systems similar to Ames test have been developed in yeast. Saccharomyces cerevisiae is generally used. These systems can check for forward and reverse mutations, as well as recombinant events.

Drosophila

Sex-Linked Recessive Lethal Test – Males from a strain with yellow bodies are used in this test. The gene for the yellow body lies on the X-chromosome. The fruit flies are fed on a diet of test chemical, and progenies are separated by sex. The surviving males are crossed with the females of the same generation, and if no males with yellow bodies are detected in the second generation, it would indicate a lethal mutation on the X-chromosome has occurred.

Plant assays

Plants such as Zea mays, Arabidopsis thaliana and Tradescantia have been used in various test assays for mutagenecity of chemicals.

Cell culture assay

Mammalian cell lines such as Chinese hamster V79 cells, Chinese hamster ovary (CHO) cells or mouse lymphoma cells may be used to test for mutagenesis. Such systems include the HPRT assay for resistance to 8-azaguanine or 6-thioguanine, and ouabain-resistance (OUA) assay.

Rat primary hepatocytes may also be used to measure DNA repair following DNA damage. Mutagens may stimulate unscheduled DNA synthesis that results in more stained nuclear material in cells following exposure to mutagens.

Chromosome check systems

These systems check for large scale changes to the chromosomes and may be used with cell culture or in animal test. The chromosomes are stained and observed for any changes. Sister chromatid exchange is a symmetrical exchange of chromosome material between sister chromatids and may be correlated to the mutagenic or carcinogenic potential of a chemical. In micronucleus Test, cells are examined for micronuclei, which are fragments or chromosomes left behind at anaphase, and is therefore a test for clastogenic agents that cause chromosome breakages. Other tests may check for various chromosomal aberrations such as chromatid and chromosomal gaps and deletions, translocations, and ploidy.

Animal test systems

Rodents are usually used in animal test. The chemicals undertest are usually administered in the food and in the drinking water, but sometimes by dermal application, by gavage, or by inhalation, and carried out over the major part of the life span for rodents. In tests that check for carcinogens, maximum tolerated dosage is first determined, then a range of doses are given to around 50 animals throughout the notional lifespan of the animal of two years. After death the animals are examined for sign of tumours. Differences in metabolism between rat and human however means that human may not respond in exactly the same way to mutagen, and dosages that produce tumours on the animal test may also be unreasonably high for a human, i.e. the equivalent amount required to produce tumours in human may far exceed what a person might encounter in real life.

Mice with recessive mutations for a visible phenotype may also be used to check for mutagens. Females with recessive mutation crossed with wild-type males would yield the same phenotype as the wild-type, and any observable change to the phenotype would indicate that a mutation induced by the mutagen has occurred.

Mice may also be used for dominant lethal assays where early embryonic deaths are monitored. Male mice are treated with chemicals under test, mated with females, and the females are then sacrificed before parturition and early fetal deaths are counted in the uterine horns.

Transgenic mouse assay using a mouse strain infected with a viral shuttle vector is another method for testing mutagens. Animals are first treated with suspected mutagen, the mouse DNA is then isolated and the phage segment recovered and used to infect E. coli. Using similar method as the blue-white screen, the plaque formed with DNA containing mutation are white, while those without are blue.

In anti-cancer therapy

Many mutagens are highly toxic to proliferating cells, and they are often used to destroy cancer cells. Alkylating agents such as cyclophosphamide and cisplatin, as well as intercalating agent such as daunorubicin and doxorubicin may be used in chemotherapy. However, due to their effect on other cells which are also rapidly dividing, they may have side effects such as hair loss and nausea. Research on better targeted therapies may reduce such side-effects. Ionizing radiations are used in radiation therapy.

In fiction

In science fiction, mutagens are often represented as substances that are capable of completely changing the form of the recipient or granting them superpowers. Powerful radiations are the agents of mutation for the superheroes in Marvel Comics's Fantastic Four, Daredevil, and Hulk, while in the Ninja Turtles franchise the MUTAGEN "ooze" for Inhumans the mutagen is the Terrigen Mist. Mutagens are also featured in video games such as Cyberia, System Shock, The Witcher, , , Resident Evil, Infamous, Freedom Force, Command & Conquer, Gears of War 3, StarCraft, BioShock, Fallout, Underrail, and Maneater.In the "nuclear monster" films of the 1950s, nuclear radiation mutates humans and common insects often to enormous size and aggression; these films include Godzilla, Them!, Attack of the 50 Foot Woman, Tarantula!, and The Amazing Colossal Man.

See also

Notes and References

  1. Papavramidou N, Papavramidis T, Demetriou T . Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer . Annals of Surgical Oncology . 17 . 3 . 665–7 . March 2010 . 20049643 . 2820670 . 10.1245/s10434-009-0886-6 .
  2. Web site: Nature and Nurture - Lessons from Chemical Carcinogenesis: Chemical Carcinogens — From Past to Present. Luch. A. www.medscape.com. registration. https://web.archive.org/web/20110319055755/http://www.medscape.com/viewarticle/499098_2. 19 March 2011. live.
  3. Book: Hill, John. Cautions against the immoderate use of snuff: founded on the known qualities of the tobacco plant: and the effects it must produce when this way taken into the body: and enforced by instances of persons who have perished miserably of diseases, occasioned, or rendered incurable by its use. Printed for Baldwin R and Jackson J. 1761. London. vanc.
  4. Brown JR, Thornton JL . Percivall Pott (1714-1788) and chimney sweepers' cancer of the scrotum . British Journal of Industrial Medicine . 14 . 1 . 68–70 . January 1957 . 13396156 . 1037746 . 10.1136/oem.14.1.68 .
  5. Yamagawa K, Ichikawa K. 1915. Experimentelle Studie über die Pathogenese der Epithelialgeschwülste. Mitteilungen aus der Medizinischen Fakultät der Kaiserlichen Universität zu Tokyo. 15. 295–344. 10.11501/1675887.
  6. Cook JW, Hewett CL, Hieger I. 1933. The isolation of a cancer-producing hydrocarbon from coal tar. J. Chem. Soc.. 24. 395–405. 10.1039/JR9330000395. dmy-all.
  7. Kathren RL. Dec 2002. Historical Development of the Linear Nonthreshold Dose-Response Model as Applied to Radiation. University of New Hampshire Law Review. 1. 1.
  8. News: "Russian Trail" in the Discovery of DNA Structure. 2004. SCIENCE First Hand. https://web.archive.org/web/20170818090349/https://scfh.ru/en/papers/quot-russian-trail-quot-in-the-discovery-of-dna-structure/. 18 August 2017. live. INFOLIO. N2. 3.
  9. Book: Bericht über das Jahr 1960. Böhme H. Springer Verlag. 1961. 978-3-642-94811-4. Bünning E, Gäumann E. 23. Berlin. 502–509. de. Angewandte Mikrobiologie. 10.1007/978-3-642-94810-7_40. Bereits kurz nach der Entdeckung der Möglichkeit einer Auslösung von Mutationen durch ionisierende Strahlen (Nadson u. Filippov 1925, 1928; Muller 1927).
  10. Calabrese EJ . Muller's Nobel lecture on dose-response for ionizing radiation: ideology or science? . Archives of Toxicology . 85 . 12 . 1495–8 . December 2011 . 21717110 . 10.1007/s00204-011-0728-8 . 4708210 . https://web.archive.org/web/20170802001406/http://users.physics.harvard.edu/~wilson/freshman_seminar/Radiation/Calabrese-Muller-1-1.pdf . live . 2 August 2017 .
  11. Muller HJ . Artificial Transmutation of the Gene . Science . 66 . 1699 . 84–7 . July 1927 . 17802387 . 10.1126/science.66.1699.84 . 1927Sci....66...84M . https://web.archive.org/web/20121030033216/http://www.esp.org/foundations/genetics/classical/holdings/m/hjm-1927a.pdf . live . 30 October 2012 .
  12. Book: Introduction to Genetic Analysis. Griffiths. Anthony J. F.. Wessler. Susan R.. Carroll. Sean B.. Doebley. John. 2012. W. H. Freeman. 978-1-4292-7634-4. 10th. 255. vanc.
  13. Altenburg E. 1928. The Limit of Radiation Frequency Effective in Producing Mutations. Am. Nat.. 62. 683. 540–545. 2457052. 10.1086/280230. 83653780.
  14. Crow JF, Abrahamson S . Seventy years ago: mutation becomes experimental . Genetics . 147 . 4 . 1491–6 . December 1997 . 10.1093/genetics/147.4.1491 . 9409815 . 1208325 .
  15. Book: Biology. Campbell NA, Reece JB. Pearson Education, Inc. 2005. 978-0-8053-7146-8. 7th. San Francisco, CA.
  16. Stadler LJ . Mutations in Barley Induced by X-Rays and Radium . Science . 68 . 1756 . 186–7 . August 1928 . 17774921 . 10.1126/science.68.1756.186 . 1928Sci....68..186S .
  17. Stadler LJ, Sprague GF . Genetic Effects of Ultra-Violet Radiation in Maize: I. Unfiltered Radiation . Proceedings of the National Academy of Sciences of the United States of America . 22 . 10 . 572–8 . October 1936 . 16588111 . 1076819 . 10.1073/pnas.22.10.572 . 1936PNAS...22..572S . Lewis Stadler . free .
  18. Hockberger PE . A history of ultraviolet photobiology for humans, animals and microorganisms . Photochemistry and Photobiology . 76 . 6 . 561–79 . December 2002 . 12511035 . 10.1562/0031-8655(2002)0760561AHOUPF2.0.CO2 . 222100404 . https://web.archive.org/web/20111117044149/http://www.photobiology.info/Hockberger.html . live . 17 November 2011 .
  19. Auerbach C, Robson JM, Carr JG . The Chemical Production of Mutations . Science . 105 . 2723 . 243–7 . March 1947 . 17769478 . 10.1126/science.105.2723.243 . 1947Sci...105..243A . Charlotte Auerbach .
  20. Ames BN, Lee FD, Durston WE . An improved bacterial test system for the detection and classification of mutagens and carcinogens . Proceedings of the National Academy of Sciences of the United States of America . 70 . 3 . 782–6 . March 1973 . 4577135 . 433358 . 10.1073/pnas.70.3.782 . 1973PNAS...70..782A . free .
  21. Ames BN . Identifying environmental chemicals causing mutations and cancer . Science . 204 . 4393 . 587–93 . May 1979 . 373122 . 10.1126/science.373122 . 1979Sci...204..587A . 1748159 . Bruce Ames .
  22. McCann J, Choi E, Yamasaki E, Ames BN . Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals . Proceedings of the National Academy of Sciences of the United States of America . 72 . 12 . 5135–9 . December 1975 . 1061098 . 388891 . 10.1073/pnas.72.12.5135 . 1975PNAS...72.5135M . 3 . free .
  23. McCann J, Gold LS, Horn L, McGill R, Graedel TE, Kaldor J . Statistical analysis of Salmonella test data and comparison to results of animal cancer tests . Mutation Research . 205 . 1–4 . 183–95 . 1988 . 3285186 . 10.1016/0165-1218(88)90017-1 . https://web.archive.org/web/20121030032731/http://potency.lbl.gov/pdfs/MutatRes88.pdf . 3 . 30 October 2012 .
  24. Dunkel VC, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF . Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli . Environmental Mutagenesis . 7 Suppl 5 . suppl. 5 . 1–248 . 1985 . 3905369 . 3 . 10.1002/em.2860070902 .
  25. Benigni R, Bossa C . Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays . Mutagenesis . 26 . 3 . 455–60 . May 2011 . 21398403 . 10.1093/mutage/ger004 . free .
  26. Web site: Toxicology And Carcinogenesis Studies Of Sodium Azide in F344/N Rats. 1991. nih.gov. NIH. technical report. https://web.archive.org/web/20111023165026/http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr389.pdf. 23 October 2011. live.
  27. Book: Hill . John . Chemistry for Changing Times . McCreary . John . . 2019 . 978-0-13-498863-4 . 15 . en . 22.6 Carcinogens and Teratogens . 10.1021/ed050pa44.2 . https://chem.libretexts.org/@go/page/152300.
  28. Salerno . Monica . Cascio . Orazio . Bertozzi . Giuseppe . Sessa . Francesco . Messina . Antonietta . Monda . Vincenzo . Cipolloni . Luigi . Biondi . Antonio . Daniele . Aurora . Pomara . Cristoforo . 2018-04-10 . Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review . Oncotarget . 9 . 27 . 19415–19426 . 10.18632/oncotarget.24767 . 1949-2553 . 5922407 . 29721213.
  29. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Lya G. Hernández . Harry van Steeg . Mirjam Luijten . Jan van Benthem . Mutation Research/Reviews in Mutation Research . 682. 2–3. 2009. 94–109 . 10.1016/j.mrrev.2009.07.002 . 19631282.
  30. Bernstein, C.; Bernstein, H. (1991). Aging, Sex, and DNA Repair. pgs. 15-16. San Diego: Academic Press.
  31. Allen JW, DeWeese GK, Gibson JB, Poorman PA, Moses MJ . Synaptonemal complex damage as a measure of chemical mutagen effects on mammalian germ cells . Mutation Research . 190 . 1 . 19–24 . January 1987 . 3099192 . 10.1016/0165-7992(87)90076-5 . 3 .
  32. Huang L, Snyder AR, Morgan WF . Radiation-induced genomic instability and its implications for radiation carcinogenesis . Oncogene . 22 . 37 . 5848–54 . September 2003 . 12947391 . 10.1038/sj.onc.1206697 . free .
  33. Durland . Justin . Ahmadian-Moghadam . Hamid . 19 September 2022 . Genetics, Mutagenesis . StatPearls . 2023 Jan . 18 November 2023.
  34. Duesberg P, Rasnick D . Aneuploidy, the somatic mutation that makes cancer a species of its own . Cell Motility and the Cytoskeleton . 47 . 2 . 81–107 . October 2000 . 11013390 . 10.1002/1097-0169(200010)47:2<81::AID-CM1>3.0.CO;2-# .
  35. Web site: Calabrese says mistake led to adopting the LNT model in toxicology. 2017. phys.org. https://web.archive.org/web/20170801234403/https://phys.org/news/2017-01-calabrese-lnt-toxicology.html. 1 August 2017. live. 24 Jan 2019. . Calabrese says mistake led to adopting the LNT model in toxicology..
  36. Klapacz J, Pottenger LH, Engelward BP, Heinen CD, Johnson GE, Clewell RA, Carmichael PL, Adeleye Y, Andersen ME . Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents . Mutation Research/Reviews in Mutation Research . 767 . 77–91 . 2016 . 27036068 . 4818947 . 10.1016/j.mrrev.2015.11.001 . 3 .
  37. Kim D, Guengerich FP . Cytochrome P450 activation of arylamines and heterocyclic amines . Annual Review of Pharmacology and Toxicology . 45 . 27–49 . 2005 . 15822170 . 10.1146/annurev.pharmtox.45.120403.100010 .
  38. Web site: Promutagen - an overview | ScienceDirect Topics.
  39. Lee SH, Williams MV, Dubois RN, Blair IA . Cyclooxygenase-2-mediated DNA damage . The Journal of Biological Chemistry . 280 . 31 . 28337–46 . August 2005 . 15964853 . 10.1074/jbc.M504178200 . 3 . free .
  40. Book: Side Effects of Drugs Annual. Lipp HP, Hartmann JT, Stanley A. Elsevier. 2005. Aronson JK. 28. 538–551. 45 - Cytostatic drugs. Side Effects of Drugs Annual ...: A Worldwide Yearly Survey of New Data and Trends. 10.1016/S0378-6080(05)80467-2. 0378-6080. 978-0-444-51571-1.
  41. Henderson JP, Byun J, Williams MV, Mueller DM, McCormick ML, Heinecke JW . Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation . The Journal of Biological Chemistry . 276 . 11 . 7867–75 . March 2001 . 11096071 . 10.1074/jbc.M005379200 . 3 . free .
  42. Yu . Hongtao . November 2002 . Environmental carcinogenic polycyclic aromatic hydrocarbons: photochemistry and phototoxicity . Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews . 20 . 2 . 149–183 . 10.1081/GNC-120016203 . 1059-0501 . 3812823 . 12515673.
  43. Book: Cooke . M. . Dennis . A. J. . 1986-01-01 . Polynuclear aromatic hydrocarbons: Chemistry, characterization and carcinogenesis . 7252502 .
  44. Nishikawa . Takuro . Miyahara . Emiko . Horiuchi . Masahisa . Izumo . Kimiko . Okamoto . Yasuhiro . Kawai . Yoshichika . Kawano . Yoshifumi . Takeuchi . Toru . January 2012 . Benzene metabolite 1,2,4-benzenetriol induces halogenated DNA and tyrosines representing halogenative stress in the HL-60 human myeloid cell line . Environmental Health Perspectives . 120 . 1 . 62–67 . 10.1289/ehp.1103437 . 1552-9924 . 3261936 . 21859636.
  45. Raquet. N. Schrenk. D. Relative photomutagenicity of furocoumarins and limettin in the hypoxanthine phosphoribosyl transferase assay in V79 cells.. Chemical Research in Toxicology. September 2009. 22. 9. 1639–47. 19725558. 10.1021/tx9002287.
  46. Valko M, Morris H, Cronin MT . Metals, toxicity and oxidative stress . Current Medicinal Chemistry . 12 . 10 . 1161–208 . 2005 . 15892631 . 10.2174/0929867053764635 . 10.1.1.498.2796 . https://web.archive.org/web/20150824003404/http://glutathioneexperts.com/pdfs/glutathione-heavy-metal-1.pdf . live . 24 August 2015 .
  47. Web site: Health Risk Assessment Guidance for Metals – Mutagenicity. 2007. EBRC. https://web.archive.org/web/20120412230532/http://www.ebrc.de/industrial-chemicals-reach/projects-and-references/downloads/HERAG_FS_05_August_07.pdf. 12 April 2012.
  48. Ellermann V. . Bang O. . Experimentelle Leukämie bei Hühnern . Zentralbl. Bakteriol. Parasitenkd. Infectionskr. Hyg. Abt. Orig. . 1908 . 46 . 595–609 .
  49. Rous P . The Journal of Experimental Medicine . 13 . 4 . 397–411 . April 1911 . 19867421 . 2124874 . 10.1084/jem.13.4.397 . A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells .
  50. Book: National Research Council, U.S.. Carcinogens and Anticarcinogens in the Human Diet. National Academies of Sciences, Engineering, and Medicine#Program units. National Academy Press. 1996. 978-0-309-05391-4. Washington, D.C.
  51. Dolara P, Bigagli E, Collins A . Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary . European Journal of Nutrition . 51 . 7 . 769–81 . October 2012 . 22684632 . 10.1007/s00394-012-0389-2 . 36973911 .
  52. Li K, Kaaks R, Linseisen J, Rohrmann S . Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg) . European Journal of Nutrition . 51 . 4 . 407–13 . June 2012 . 21779961 . 10.1007/s00394-011-0224-1 . 1692747 . 3 .
  53. Gibbs A, Schwartzman J, Deng V, Alumkal J . Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6 . Proceedings of the National Academy of Sciences of the United States of America . 106 . 39 . 16663–8 . September 2009 . 19805354 . 2757849 . 10.1073/pnas.0908908106 . 2009PNAS..10616663G . 3 . free .
  54. Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O . Cancer prevention with natural compounds . Seminars in Oncology . 37 . 3 . 258–81 . June 2010 . 20709209 . 10.1053/j.seminoncol.2010.06.014 . 3 .
  55. Web site: Skin Cancer Facts and Figures. Cancer Council. https://web.archive.org/web/20120810071104/http://www.cancer.org.au/cancersmartlifestyle/SunSmart/Skincancerfactsandfigures.htm. 10 August 2012. 2 Jul 2010.
  56. News: Skin-tone gene could predict cancer risk. Callaway. E. 2008. New Scientist. 24 Jan 2019. https://web.archive.org/web/20150424063714/http://www.newscientist.com/article/dn13922-skintone-gene-could-predict-cancer-risk.html. 24 April 2015. live.
  57. Doll R, Peto R . The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today . Journal of the National Cancer Institute . 66 . 6 . 1191–308 . June 1981 . 7017215 . 10.1093/jnci/66.6.1192 .
  58. Willett WC . Diet, nutrition, and avoidable cancer . Environmental Health Perspectives . 103 . Suppl 8 . 165–70 . November 1995 . 8741778 . 1518978 . 10.1289/ehp.95103s8165 .
  59. Web site: Polycyclic Aromatic Hydrocarbons – Occurrence in foods, dietary exposure and health effects. Scientific Committee on Food. 4 Dec 2002. European Commission. https://web.archive.org/web/20110519225348/http://ec.europa.eu/food/fs/sc/scf/out154_en.pdf. 19 May 2011. 21 Aug 2010.
  60. News: Roast potatoes and toast that's a bit too brown may cause cancer, say authorities. Siddique. Haroon. 23 Jan 2017. The Guardian. https://web.archive.org/web/20170123142506/https://www.theguardian.com/world/2017/jan/23/toast-thats-a-bit-too-brown-may-cause-cancer-say-authorities. 23 January 2017. live.
  61. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M . Analysis of acrylamide, a carcinogen formed in heated foodstuffs . Journal of Agricultural and Food Chemistry . 50 . 17 . 4998–5006 . August 2002 . 12166997 . 10.1021/jf020302f .
  62. Pöschl G, Seitz HK . Alcohol and cancer . Alcohol and Alcoholism . 39 . 3 . 155–65 . 2004 . 15082451 . 10.1093/alcalc/agh057 .
  63. Book: Genetics and the Law II. Milunsky A, Annas GJ. Springer US. 1980. 978-1-4613-3080-6. Boston, MA.
  64. Book: A Textbook of Modern Toxicology. Hodgson. Ernest. John Wiley & Sons. 2004. 978-0-471-26508-5. 3rd. Chapter 21. vanc.
  65. Book: Principles of Toxicology – Environmental and Industrial Applications. Williams. Phillip L.. James. Robert C.. Roberts. Stephen M.. John Wiley & Sons. 2000. 978-0-471-29321-7. 2nd. vanc.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mutagen".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.